Suppr超能文献

一种递药系统,可避免自聚集,并提高用于光动力疗法的酞菁衍生物的体外和体内经皮递药。

A delivery system to avoid self-aggregation and to improve in vitro and in vivo skin delivery of a phthalocyanine derivative used in the photodynamic therapy.

机构信息

Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

出版信息

J Control Release. 2011 Nov 7;155(3):400-8. doi: 10.1016/j.jconrel.2011.06.034. Epub 2011 Jul 7.

Abstract

The hydrophilic character and aggregation phenomena exhibited by the photosensitizer zinc phthalocyanine tetrasulfonate (ZnPcSO(4)) make it difficult for this compound to penetrate the skin, and reduce the compound's photodynamic efficacy. A microemulsion (ME) was developed to increase the skin penetration of ZnPcSO(4) while avoiding its aggregation. Ternary phase diagrams composed of surfactants (Span® 80/Tween® 80), canola oil and a propylene glycol (PG)/water mixture (3:1) were constructed as a basis for choosing an adequate ME preparation. Rheological, electrical conductivity, dynamic light scattering and zeta potential studies were carried out to characterize the ME formulations. Monomerization of ZnPcSO(4) in the ME was determined photometrically and fluorometrically. In vitro skin penetration and retention of the compound in the skin were measured using porcine ear skin mounted on a diffusion cell apparatus. The in vivo accumulation 6h after ZnPcSO(4) application was determined fluorometrically in hairless mice skin. Confocal laser scanning microscopy was used to visualize ZnPcSO(4) distribution in the skin. A ME composed of canola oil:surfactant:PG-water at 38:47:15 (w/w/w) was chosen for ZnPcSO(4.) This was oil-in-water with internal phase diameter of 15.7±0.15nm. Spectroscopic techniques confirmed that the ME was able to keep ZnPcSO(4) in its monomeric form. In the in vitro penetration of ZnPcSO(4) in the stratum corneum (SC) and in epidermis (without stratum corneum) with dermis ([E+D]) was 33.0- and 28.0-fold higher, respectively compared to the control solution of the drug. In vivo studies, confirmed that when the ME was used as carrier, ZnPcSO(4) concentrations in the SC and [E+D] were about 1.6- and 5.6-fold higher, respectively, than controls. Visualization of ZnPcSO(4) skin penetration by confocal laser scanning microscopy confirmed that the ME increased both penetration and biodistribution of this photosensitizer in the skin.

摘要

锌酞菁四磺酸酯(ZnPcSO(4))具有亲水性和聚集现象,这使得该化合物难以穿透皮肤,并降低了化合物的光动力疗效。开发了一种微乳液(ME)来增加 ZnPcSO(4)的皮肤穿透性,同时避免其聚集。由表面活性剂(Span®80/Tween®80)、菜籽油和丙二醇(PG)/水混合物(3:1)组成的三元相图被构建作为选择合适的 ME 制剂的基础。流变学、电导率、动态光散射和zeta 电位研究用于表征 ME 配方。通过光度法和荧光法确定 ME 中 ZnPcSO(4)的单体化。使用安装在扩散池装置上的猪耳皮测量化合物在皮肤中的体外渗透和保留。在无毛小鼠皮肤中,通过荧光法测定 ZnPcSO(4)应用 6 小时后的体内积累。使用共聚焦激光扫描显微镜可视化皮肤中 ZnPcSO(4)的分布。选择由菜籽油:表面活性剂:PG-水组成的 ME 为 38:47:15(w/w/w)。这是油包水型,内相直径为 15.7±0.15nm。光谱技术证实 ME 能够使 ZnPcSO(4)保持单体形式。与药物对照溶液相比,ZnPcSO(4)在角质层(SC)和表皮(无角质层)和真皮中的体外渗透(E+D)分别高 33.0 倍和 28.0 倍。体内研究证实,当 ME 用作载体时,SC 和 [E+D]中的 ZnPcSO(4)浓度分别比对照高约 1.6 倍和 5.6 倍。通过共聚焦激光扫描显微镜对 ZnPcSO(4)皮肤渗透的可视化证实,ME 增加了该光敏剂在皮肤中的渗透和生物分布。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验